Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Monique Gary"'
Autor:
Brent Mabey, Elisha Hughes, Braden Probst, Holly Pederson, Timothy Simmons, Brian Morris, Brooke Hullinger, Susan Domchek, Charis Eng, Monique Gary, Jennifer Klemp, Semanti Mukherjee, Joseph Vijai, Kenneth Offit, Olufunmilayo Olopade, Sandhya Pruthi, Allison Kurian, Mark Robson, Pat Whitworth, Susanne Wagner, Jerry Lanchbury, Thomas Slavin, Alexander Gutin
Publikováno v:
Genetics in Medicine Open, Vol 1, Iss 1, Pp 100082- (2023)
Externí odkaz:
https://doaj.org/article/32bed194eef5483cbef9262feee8f2d8
Autor:
Elisha Hughes, Ryan Bernhisel, Holly Pederson, Braden Probst, Timothy Simmons, Susanne Wagner, Thaddeus Judkins, Eric Rosenthal, Benjamin Roa, Susan M. Domchek, Charis Eng, Judy Garber, Monique Gary, Ora K. Gordon, Jennifer Klemp, Semanti Mukherjee, Kenneth Offit, Funmi Olopade, Joseph Vijai, Jeffrey N. Weitzel, Pat Whitworth, Lamis Yehia, Allison Kurian, Mark Robson, Thomas P. Slavin, Alexander Gutin, Jerry S. Lanchbury
Publikováno v:
Cancer Research. 82:P2-11
Background: Polygenic risk scores (PRS) have been shown to provide genomically informed breast cancer risk assessment in both carriers and non-carriers of predisposing genetic mutations. Risk stratification is further improved by combining a PRS with
Autor:
Brent Mabey, Elisha Hughes, Braden Probst, Holly J. Pederson, Timothy Simmons, Brian Morris, Brooke Hullinger, Susan Domchek, Charis Eng, Monique Gary, Jennifer Klemp, Semanti Mukherjee, Vijai Joseph, Kenneth Offit, Olufunmilayo I. Olopade, Sandhya Pruthi, Allison W. Kurian, Mark E. Robson, Pat Whitworth, Susanne Wagner, Jerry Lanchbury, Thomas Slavin, Alexander Gutin
Publikováno v:
Cancer Research. 83:PD14-05
Background: Personalized breast cancer (BC) risk assessment depends on known traditional risk factors, specific germline mutations, and genome-wide polygenic risk scores (PRS). PRS explains a substantial proportion of genetic BC susceptibility. Accur
Autor:
Elisha Hughes, Susanne Wagner, Dmitry Pruss, Ryan Bernhisel, Braden Probst, Victor Abkevich, Timothy Simmons, Brooke Hullinger, Thaddeus Judkins, Eric Rosenthal, Benjamin Roa, Susan M. Domchek, Charis Eng, Judy Garber, Monique Gary, Jennifer Klemp, Semanti Mukherjee, Kenneth Offit, Olufunmilayo I. Olopade, Joseph Vijai, Jeffrey N. Weitzel, Pat Whitworth, Lamis Yehia, Ora Gordon, Holly Pederson, Allison Kurian, Thomas P. Slavin, Alexander Gutin, Jerry S. Lanchbury
Publikováno v:
JCO Precision Oncology.
PURPOSE Polygenic risk scores (PRSs) for breast cancer (BC) risk stratification have been developed primarily in women of European ancestry. Their application to women of non-European ancestry has lagged because of the lack of a formal approach to in
Autor:
Elisha Hughes, Braden Probst, Holly Jane Pederson, Timothy Simmons, Brian Morris, Susan M. Domchek, Charis Eng, Monique Gary, Ora Gordon, Jennifer R. Klemp, Semanti Mukherjee, Kenneth Offit, Olufunmilayo I. Olopade, Mark E. Robson, Joseph Vijai, Pat W. Whitworth, Susanne Wagner, Jerry Lanchbury, Thomas Paul Slavin, Alexander Gutin
Publikováno v:
Journal of Clinical Oncology. 40:557-557
557 Background: BC risk assessment is important for guiding personalized screening and risk-reducing interventions. TCv8 is used to estimate BC risk based on age, breast density, family cancer history and other clinical factors. Accuracy may be impro
Autor:
Stephanie Meek, Placede Tiemeny, Jennifer R. Klemp, Alexander Gutin, Shannon Gallagher, Jeffrey N. Weitzel, Olufunmilayo I. Olopade, Susanne Wagner, Jerry S. Lanchbury, Charis Eng, Elisha Hughes, Thomas P. Slavin, Holly J. Pederson, Ora Gordon, Monique Gary, Pat Whitworth, Lamis Yehia
Publikováno v:
Journal of Clinical Oncology. 39:10502-10502
10502 Background: BC risk is influenced by single-nucleotide polymorphisms (SNPs) with small effects that can be aggregated into polygenic risk scores (PRSs). PRSs have primarily been developed and validated for populations of European descent. To ma
Autor:
Shawna C. Willey, Danjing Zhao, Patricia Wehner, Surupa Sen Gupta, Bridget A. Oppong, Mihriye Mete, Sulakshana Seevaratnam, Monique Gary, Sonali Rudra
Background: Intraoperative radiotherapy (IORT) has gained momentum for early stage and favorable breast cancers (BC). The 21-gene recurrence assay guides treatment of hormone positive and node-negative BC. Methods: Analysis of 82 invasive BC treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55bc0bee4a9a90fd03bcbc7f4e64da0e
https://europepmc.org/articles/PMC5750322/
https://europepmc.org/articles/PMC5750322/
Autor:
Monique Gary, Timothy C. Counihan, Gray Ellrodt, Sharyl Tutela, Enrique Lopez, Richard Glasener
Publikováno v:
American Journal of Medical Quality. 31:31-37
An analysis of outcomes, quality, and survey data was carried out to evaluate the impact of surgical multidisciplinary rounds (SMDR) at a community teaching hospital. Surgical inpatients were reviewed over a 4-year period. Real-time changes to clinic